What happens after stopping Zepbound® or Wegovy®?

Stopping a GLP-1 medication like Wegovy® or Zepbound® is a big step. You may wonder what happens to your weight next.

Maybe the scale finally moved after years of trying. The thought of stopping can feel hopeful and scary at once.

You deserve honest information, not fear. Here is what the trials found, and what they may mean for you.

Why stopping a GLP-1 medication can lead to weight regain

Obesity is a long-term condition, much like high blood pressure. GLP-1 medicines like Wegovy® and Zepbound® help manage it while you take them.

Your body works hard to defend its weight. After weight loss, hunger hormones often rise and fullness signals often fall.

GLP-1 medicines like Wegovy® and Zepbound® help balance those signals. They copy a gut hormone that tells your brain you feel full.

When the medicine stops, its effects fade. The older, stronger hunger signals can return over the weeks that follow.

So weight regain after stopping is expected. It is a class pattern seen across GLP-1 medicines, not a personal failure.

This is true for many people, at many sizes. The stronger the loss, the harder the body may push to regain it.

Doctors now view this much like other long-term conditions. Many people stay on treatment to keep the benefit going.

Knowing this ahead of time helps you plan. It turns a surprise into something you can prepare for with your prescriber.

Weight regain after stopping is not a sign you did anything wrong. It is how a long-term condition behaves.

Wegovy® after stopping: what the STEP 1 extension found

Wegovy® (brand of semaglutide) was studied in the STEP 1 trial. Adults took Wegovy® 2.4 mg for 68 weeks.

In that trial, Wegovy® 2.4 mg led to about -14.9% weight change. Placebo led to about -2.4%, across 1,961 adults.

The STEP 1 extension then followed people after the trial. It gave researchers a rare look at life after stopping Wegovy®.

By one year off the medicine, the results shifted. The change was gradual, not sudden, across the months that followed.

Participants regained about two-thirds of the weight they had lost. This happened within about a year of stopping Wegovy®.

Two-thirds is a lot, but it is not everything. On average, people kept about a third of what they had lost.

At week 120, the net change was about -5.6% for the Wegovy® group. The placebo group sat near -0.1% from baseline.

So most, but not all, of the early loss came back. Some benefit remained a year after stopping.

The trial gives us numbers, but your body is not a number. Still, the pattern it shows is a helpful guide for planning.

Zepbound® after stopping: what SURMOUNT-4 found

Zepbound® (brand of tirzepatide) was studied in the SURMOUNT-4 trial. This trial was built to look closely at stopping.

First, everyone took Zepbound® for a 36-week lead-in. On average, they lost about -20.9% of their weight.

The design makes the result easy to read. After the lead-in, the only real change was whether people kept taking Zepbound®.

SURMOUNT-4 studied adults with obesity or extra weight. It focused on what happens when treatment stops or continues.

Then the group split. Some kept taking Zepbound®, and some switched to placebo.

The placebo group regained a mean of about +14.0% of body weight. Those who kept taking Zepbound® lost a further -5.5%.

The gap between the two groups was about 19.4 percentage points. This trial included 670 adults.

That gap of about 19.4 points shows the medicine's ongoing role. It is the difference staying on Zepbound® made in the trial.

The lesson is clear. Stopping led to steady regain, while continuing held the loss and added a little more.

Brand (active drug)	Trial	Weight change on treatment	After stopping
Wegovy® (brand of semaglutide)	STEP 1 + extension, N=1,961	About -14.9% at 68 weeks	About two-thirds regained; net about -5.6% at week 120
Zepbound® (brand of tirzepatide)	SURMOUNT-4, N=670	About -20.9% over 36-week lead-in	Placebo group regained a mean of about +14.0%
Zepbound® (brand of tirzepatide)	SURMOUNT-4, N=670	Continued treatment	Lost a further -5.5%; group gap about 19.4 points

Weight regain after stopping in branded GLP-1 trials. Figures are trial averages.

Both trials point the same way. Weight tends to return after stopping, and the more you lost, the more there may be to regain.

The trials agree. Stopping tends to reverse the loss over time, while staying on treatment tends to protect it.

Does any benefit remain after stopping Wegovy® or Zepbound®?

The trials offer a hopeful note. In both, people who stopped still weighed less than when they began.

In the Wegovy® group, some loss stayed a year after stopping. The net change stayed below where people started at week 120.

Still, most of the early loss returned in both trials. The benefit of the medicine is strongest while you keep taking it.

That is why obesity care often looks long-term. Like blood pressure care, the results tend to last as long as treatment does.

Think of the medicine as support, not a one-time fix. It works while it is on board, much like many daily treatments.

How weight regain tends to unfold after stopping

Regain does not happen overnight after stopping Wegovy® or Zepbound®. It builds gradually over months, much like the loss did.

1. First weeks: appetite and hunger often start to return as the medicine leaves your body.

2. First few months: many people notice the scale creeping up as old habits feel easier again.

3. Around one year: trials saw much of the lost weight return, though some benefit often remained.

4. Long term: without treatment or new habits, weight often drifts back toward the starting point.

Everyone is different, so your path may not match a trial exactly. Genetics, habits, and health all play a part.

Small, steady habits matter more than any single week. What you do over months helps shape where your weight lands.

There is no clock that fits everyone here. Some people hold steady longer, and others regain a bit faster.

What to discuss with your prescriber before stopping Wegovy® or Zepbound®

Any change to a GLP-1 medication is a conversation for you and your prescriber. There is no set taper or maintenance dose on the label.

Your prescriber can look at your full health picture. Together you can weigh the benefits of staying on against your reasons for stopping.

Why you want to stop, and what you hope will happen next.

How the trials showed weight often returns after stopping.

What a long-term plan for your weight could look like.

How to protect habits like protein, movement, and sleep.

Any side effects or concerns that are driving your decision.

Access, side effects, and daily life are all fair reasons to reassess. Your prescriber can help you sort through them with facts.

If you do stop, you can still support your health. Steady habits with food, movement, and sleep may help slow regain.

It can help to track a few simple things. Your weight, appetite, and how you feel are all worth noting between visits.

There is no magic switch to keep the weight off. A plan made with your prescriber gives you the best footing.

Do not stop or change your dose on your own. Your prescriber can guide the safest next step for you.

The safest plan is the one you build with your prescriber. Bring your questions, and decide together.

These results apply only to the FDA-approved branded product, not to compounded preparations. Compounded versions are not FDA-approved, are not a generic of Wegovy® or Zepbound®, and are not evaluated by the FDA for safety, effectiveness, or quality.

Frequently asked questions

What happens to my weight after stopping Wegovy® or Zepbound®?

For most people, weight starts to return after stopping. Appetite and fullness signals fade as the medicine leaves your body. In the trials, much of the lost weight came back within about a year. Some benefit often remained. This is expected, because obesity is a long-term condition, not a short-term problem.

How much weight did people regain in the Wegovy® trial?

In the Wegovy® (brand of semaglutide) STEP 1 extension, people regained about two-thirds of the weight they had lost. This happened within about one year of stopping. At week 120, the net change was about -5.6% for the Wegovy® group. The placebo group sat near -0.1% from baseline. So some benefit stayed, but most of the early loss returned.

How much weight did people regain after stopping Zepbound®?

In Zepbound®'s (brand of tirzepatide) SURMOUNT-4 trial, everyone first lost about -20.9% over a 36-week lead-in. Then the group split. People who switched to placebo regained a mean of about +14.0% of body weight. People who kept taking Zepbound® lost a further -5.5%. The gap between the two groups was about 19.4 percentage points.

Why does weight come back after stopping a GLP-1 medication?

GLP-1 medicines like Wegovy® and Zepbound® lower appetite while you take them. When you stop, that effect fades. Hunger and fullness signals often return closer to where they began. Obesity is a long-term condition, so the body tends to drift back. Weight regain after stopping is a class pattern, not a personal failure.

How fast does weight regain happen after stopping?

Regain is gradual, not sudden. In the first weeks, appetite often returns as the medicine clears. Over the next months, the scale may slowly climb. In the trials, much of the lost weight returned within about a year of stopping. Your own pace depends on your habits, genetics, and health, so it may look different.

Is there a way to stop Wegovy® or Zepbound® without regaining weight?

There is no set taper or maintenance dose on the label for stopping. The trials suggest that stopping tends to lead to regain over time. Staying on treatment held the loss and even added a little more. If you are thinking about stopping, talk with your prescriber. Together you can build a plan that fits your health and goals.

Should I stop taking my GLP-1 medication?

That is a personal choice, and it belongs with you and your prescriber. Obesity is a long-term condition, so many people stay on treatment to keep the benefit. Others stop for their own reasons. Whatever you choose, do not change your dose on your own. Your prescriber can guide the safest next step.

Will I gain back all the weight if I stop?

Not always all of it, at least not right away. In the trials, people who stopped still weighed less than at the start after about a year. But most of the early loss did return over time. Without treatment or strong new habits, weight often keeps drifting back toward baseline. Your prescriber can help you plan for this.

Important: This page is for education only and is not medical advice. Any medicines named here are available by prescription. Always talk to a licensed clinician about medicines, symptoms, or anything you are considering.